A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure

American Journal of Cardiology

Volumn 104, Issue 9, 2009, Pages 1292-1295

  Park, Sang Hyun ^a   Kim, Weon ^b   Park, Chung Su ^a   Kang, Won Yu ^a   Hwang, Sun Ho ^a   Kim, Wan ^a  

^a Gwangju Veterans Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; PURINERGIC P2Y12 RECEPTOR;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOGENESIS; THROMBOSIS; TREATMENT DURATION; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TICLOPIDINE;

EID: 71749116951     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.049     Document Type: Article

References (13)

1. Gurbel P.A., Blinden K.P., Hiatt B.L., and O'Connor C.M. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107 (2003) 2908-2913
2. Serebruany V.L., Steinhubl S.R., Berger P.B., Malinin A.I., Bhatt D.L., and Topol E.J. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 45 (2005) 246-251
3. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., Ramírez C., Barrera-Ramirez C., Sabaté M., Hernández R., Moreno R., Escaned J., Alfonso F., Bañuelos C., Costa M.A., Bass T.A., and Macaya C. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res 115 (2005) 101-108
4. Kim J.Y., and Yoon J.H. Aspirin and clopidogrel resistance in drug eluting stent era. Korean Circ J 37 (2007) 135-147
5. Michos E.D., Ardehali R., Blumenthal R.S., Large R.A., and Ardehali H. Aspirin and clopidogrel resistance. Mayo Clin Proc 81 (2006) 518-526
6. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., Alfonso F., Macaya C., Bass T.A., and Costa M.A. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 49 (2007) 1505-1516
7. Fontana P., Dupont A., Gandrille S., Bachelot-Loza C., Reny J.L., Aiach M., and Gaussem P. Adenosine disphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108 (2003) 989-995
8. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., Kim S.W., Bui A., Gevorkian N., Xue Z., Smith K., Fournadjieva J., Suddath W.O., Satler L.F., Pichard A.D., Kent K.M., and Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
9. Jacques M., Nicolas D., Jean M.L., Jean M.F., Jean L.B., Stephanie M., Alison F., Jean L.Q., Hélène E., and Gérald V. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients. J Am Coll Cardiol 50 (2007) 501-508
10. von Beckerath N., Kastrati A., Wieczorek A., Pogatsa-Murray G., Sibbing D., Graf I., and Schömig A. A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75mg of clopidogrel for 30 days. Eur Heart J 28 (2007) 1814-1819
11. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., Ramírez C., Sabaté M., Jimenez-Quevedo P., Hernández R., Moreno R., Escaned J., Alfonso F., Bañuelos C., Costa M.A., Bass T.A., and Macaya C. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54 (2005) 2430-2435
12. Angiolillo D.J., Shoemaker S.B., Desai B., Yuan H., Charlton R.K., Bernardo E., Zenni M.M., Guzman L.A., Bass T.A., and Costa M.A. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. Circulation 115 (2007) 708-716
13. Lordkipanidz M., Pharand C., Schampaert E., Turgeon J., Palisaitis D.A., and Diodati J.G. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 28 (2007) 1702-1708